Tests robotic and virtual reality rehabilitation for older adults with Parkinson's disease
Tests robotic devices in rehabilitation for older people with Parkinson's disease.
Key facts
- Who runs it
- Istituto Nazionale di Ricovero e Cura per Anziani
- Where
- Ancona and Fermo, ItalySee the 2 sites
- Trial code
- Registry title
- Innovative Models in the Rehabilitation of the Elderly With Parkinson's Disease Through Technological Innovation
- Status
- Recruiting
- People taking part
- 195 people, planned
- Started
- 3 Dec 2019
- Expected to end
- 31 Dec 2026
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- control arm
- virtual reality games
- robotic treadmill
- Record updated
- 23 October 2023
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people aged 65 or older with Parkinson's disease at an early to middle stage, who can still walk with some help. It tests rehabilitation with robotic devices.
- Age
- 65 years or older
- Sex
- All sexes can join.
- Disease stage
- Parkinson's disease, Hoen and Yahr scale stage 1-3; FAC ≤ 2; Ranking scale score ≤ 3.
- Earlier treatment
- Drug treatment must have been stable for at least 1 month.
- Biomarker or test result
- Geriatric Depression Scale 5-items: negative.
Main reasons for not taking part
- Taking part in other studies at the same time
- No written informed consent
- Clinical dementia rating (CDR) score ≥ 3
- Fainting, epilepsy or vertigo not controlled by drugs
- Other neurological diseases at the same time
The registry criteria, word for word
Show all 14 criteriaShow less
Who can take part
- Hoen and Yahr scale: 1-3 stage
- FAC ≤ 2
- Ranking scale score ≤ 3
- Stability of drug treatment for at least 1 month
- Geriatric Depression Scale 5-items: negative
Who cannot take part
- Concomitant participation in other studies
- Concurrent neurological diseases
- Clinical dementia rating (CDR) score ≥ 3
- History of syncopal episodes, epilepsy and vertigo not controlled pharmacologically
- Severe behavioral syndromes not compensated by drugs
- Severe systemic diseases with life expectancy < 1 year
- Lack of written informed consent
- Serious dysfunction of the autonomic system
- Patients unable to follow up
Where in Italy
- IRCCS INRCA HospitalAncona, ItalyContact: Elvira MaranesiTaking people
- IRCCS INRCA HospitalFermo, ItalyContact: Valentina Di DonnaTaking people
About the trial
What the trial wants to find out
The final goal of the present study is to propose a new approach in the Parkinson's Disease rehabilitation, focused on the use of robotic devices and to check the results not only at the end of the treatment but also in the long term, foreseeing 3 follow-up.
The 3 groups in the trial
- control armExisting treatment, for comparison
Ten traditional treatment sessions divided into 2 training sessions per week for 5 weeks
- virtual reality games armTreatment being tested
Ten technological treatment sessions divided into 2 training sessions per week for 5 weeks
Treatment: virtual reality games
- robotic treadmill armTreatment being tested
Ten technological treatment sessions divided into 2 training sessions per week for 5 weeks
Treatment: robotic treadmill
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Assistive Robotic in the Elderly: Innovative Models in the Rehabilitation of the Elderly With Parkinson's Disease Through Technological Innovation
- Plain-language title
- Tests robotic and virtual reality rehabilitation for older adults with Parkinson's diseaseGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 23 October 2023